Cerebrovascular Diseases
10
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD
Computer-Aided Prevention System
Functional Recovery Effects on Comprehensive Rehabilitation for Post-acute Care -Cerebrovascular Diseases